Table of Contents Author Guidelines Submit a Manuscript
International Journal of Nephrology
Volume 2015, Article ID 523521, 6 pages
http://dx.doi.org/10.1155/2015/523521
Research Article

Glycaemic Control Impact on Renal Endpoints in Diabetic Patients on Haemodialysis

Royal London Hospital, Whitechapel Road, London E1 1BB, UK

Received 6 July 2015; Revised 4 September 2015; Accepted 6 September 2015

Academic Editor: Alessandro Amore

Copyright © 2015 Danielle Creme and Kieran McCafferty. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. NHS, Diabetes with Kidney Disease: Key Facts, 2011, http://www.yhpho.org.uk/resource/view.aspx?RID=105786.
  2. Diabetes UK, “Diabetes facts and stats,” 2014, http://www.diabetes.org.uk/Documents/About%20Us/Statistics/Diabetes-key-stats-guidelines-April2014.pdf.
  3. D. Ansell, J. Feehally, D. Fogarty et al., “UK renal registry 2009: the twelfth annual report of the renal association,” Nephron Clinical Practice, vol. 115, supplement 1, 2010. View at Google Scholar
  4. F. Caskey, A. Davenport, A. Dawnay et al., “UK renal registry 2013 16th annual report of the renal association,” Nephron Clinical Practice, vol. 125, no. 1–4, 2013. View at Google Scholar
  5. W. Schrag, “Diabetes: the dialysis outcomes practice patterns study (DOPPS) results and innovative patient care programs,” The Journal Of Nephrology Social Work, vol. 26, 2007. View at Google Scholar
  6. J. Hoshino, M. Z. Molnar, K. Yamagata et al., “Developing an HbA1c-based equation to estimate blood glucose in maintenance hemodialysis patients,” Diabetes Care, vol. 36, no. 4, pp. 922–927, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Speeckaert, W. Van Biesen, J. Delanghe et al., “Are there better alternatives than haemoglobin A1c to estimate glycaemic control in the chronic kidney disease population?” Nephrology Dialysis Transplantation, vol. 29, no. 12, pp. 2167–2177, 2014. View at Publisher · View at Google Scholar
  8. C.-M. Zheng, W.-Y. Ma, C.-C. Wu, and K.-C. Lu, “Glycated albumin in diabetic patients with chronic kidney disease,” Clinica Chimica Acta, vol. 413, no. 19-20, pp. 1555–1561, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. F. E. Vos, J. B. Schollum, and R. J. Walker, “Glycated albumin is the preferred marker for assessing glycaemic control in advanced chronic kidney disease,” NDT Plus, vol. 4, no. 6, pp. 368–375, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. K. Fukuoka, K. Nakao, H. Morimoto et al., “Glycated albumin levels predict long-term survival in diabetic patients undergoing haemodialysis,” Nephrology, vol. 13, no. 4, pp. 278–283, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. R. H. K. Mak, “Impact of end-stage renal disease and dialysis on glycemic control,” Seminars in Dialysis, vol. 13, no. 1, pp. 4–8, 2000. View at Google Scholar · View at Scopus
  12. S. P. B. Ramirez, K. P. McCullough, J. R. Thumma et al., “Hemoglobin A1c levels and mortality in the diabetic hemodialysis population: findings from the Dialysis Outcomes and Practice Patterns Study (DOPPS),” Diabetes Care, vol. 35, no. 12, pp. 2527–2532, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. National Kidney Foundation, KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update, 2012, https://www.kidney.org/sites/default/files/docs/diabetes-ckd-update-2012.pdf.
  14. The Renal Association, “Detection, Monitoring and Care of Patients with CKD,” 2011, http://www.renal.org/Clinical/GuidelinesSection/Detection-Monitoring-and-Care-of-Patients-with-CKD.
  15. C. J. Hill, A. P. Maxwell, C. R. Cardwell et al., “Glycated hemoglobin and risk of death in diabetic patients treated with hemodialysis: a meta-analysis,” American Journal of Kidney Diseases, vol. 63, no. 1, pp. 84–94, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Ricks, M. Z. Molnar, C. P. Kovesdy et al., “Glycemic control and cardiovascular mortality in hemodialysis patients with diabetes: a 6-year cohort study,” Diabetes, vol. 61, no. 3, pp. 708–715, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. S. M. O'Toole, S. L. Fan, M. M. Yaqoob, and T. A. Chowdhury, “Managing diabetes in dialysis patients,” Postgraduate Medical Journal, vol. 88, no. 1037, Article ID 130354, pp. 160–166, 2011. View at Publisher · View at Google Scholar
  18. C. Zoccali, F. A. Benedetto, G. Tripepi, and F. Mallamaci, “Cardiac consequences of hypertension in hemodialysis patients,” Seminars in Dialysis, vol. 17, no. 4, pp. 299–303, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. N. Sharpe, “Left ventricular remodeling: pathophysiology and treatment,” Heart Failure Monitor, vol. 4, no. 2, pp. 55–61, 2003. View at Google Scholar · View at Scopus
  20. KDOQI, Clinical Practice Guidelines for Cardiovascular Disease in Dialysis Patients, 2005, http://www2.kidney.org/professionals/KDOQI/guidelines_cvd/.
  21. J. E. Flythe, A. V. Kshirsagar, R. J. Falk, and S. M. Brunelli, “Associations of posthemodialysis weights above and below target weight with all-cause and cardiovascular mortality,” Clinical Journal of the American Society of Nephrology, vol. 10, no. 5, pp. 808–816, 2015. View at Publisher · View at Google Scholar
  22. A. Davenport, “Interdialytic weight gain in diabetic haemodialysis patients and diabetic control as assessed by glycated haemoglobin,” Nephron: Clinical Practice, vol. 113, no. 1, pp. c33–c37, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. S. S. Waikar, G. C. Curhan, and S. M. Brunelli, “Mortality associated with low serum sodium concentration in maintenance hemodialysis,” The American Journal of Medicine, vol. 124, no. 1, pp. 77–84, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Hecking, A. Karaboyas, R. Saran et al., “Predialysis serum sodium level, dialysate sodium, and mortality in maintenance hemodialysis patients: the Dialysis Outcomes and Practice Patterns Study (DOPPS),” American Journal of Kidney Diseases, vol. 59, no. 2, pp. 238–248, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. D. Poulikakos, V. Marks, N. Lelos, and D. Banerjee, “Low serum sodium is associated with protein energy wasting and increased interdialytic weight gain in haemodialysis patients,” Clinical Kidney Journal, vol. 7, no. 2, pp. 156–160, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. T. Yamamoto, S. Shoji, T. Yamakawa et al., “Predialysis and postdialysis ph and bicarbonate and risk of all-cause and cardiovascular mortality in long-term hemodialysis patients,” American Journal of Kidney Diseases, vol. 66, no. 3, pp. 469–478, 2015. View at Publisher · View at Google Scholar
  27. M. Kaminski, A. Raspovic, L. McMahon et al., “Risk factors for foot ulceration and lower extremity amputation in adults with end-stage renal disease on dialysis: a systematic review and meta-analysis,” Nephrology Dialysis Transplantation, 2015. View at Publisher · View at Google Scholar
  28. S. D. McMurray, G. Johnson, S. Davis, and K. McDougall, “Diabetes education and care management significantly improve patient outcomes in the dialysis unit,” American Journal of Kidney Diseases, vol. 40, no. 3, pp. 566–575, 2002. View at Publisher · View at Google Scholar · View at Scopus